The Latest | Council For Citizens Against Government Waste

The Latest

The WasteWatcher

BEAD Requirements Should Be Rolled Back

NTIA's complicated guidance and approval process has delayed infrastructure deployment of broadband using BEAD funding.

Deborah Collier February 13, 2025
State Action

CCAGW Urges Oklahoma Legislators to Oppose House Bill 2048

HB 2048 would change how the federal 340B Drug Pricing Program operates in Oklahoma. 

Alec Mena February 12, 2025
The WasteWatcher

340B Must Be Reformed in the 119th Congress

340B reform should not only should be acted on by Congress, but also reviewed by DOGE.

Christina Smith February 12, 2025
State Action

CCAGW Urges Utah Legislators to Oppose Senate Bill 69

SB 69 would change how the federal 340B Drug Pricing Program operates in the Beehive State. 

Alec Mena February 11, 2025
The WasteWatcher

A Penny Saved From Production Means Dollars Earned for Taxpayers

President Trump's announcement that the U.S. Mint will halt production of the penny is good news for taxpayers.

Deborah Collier February 11, 2025
The WasteWatcher

USPS Reforms Must Be Included in Reconciliation

Congress must include reforms to the USPS in reconciliation and DOGE should take a close look as well.

Thomas Schatz February 11, 2025
State Action

CCAGW Urges Virginia Senators to Oppose HB 1724

HB 1724 would impose price controls on prescription drugs.

Alec Mena February 10, 2025
The WasteWatcher

Joint Strike Fighter Limited by Inadequate Software

The F-35’s software development is plagued by underperformance and delays, raising serious concerns about the JSF’s reliability.

Sean Kennedy February 10, 2025
The WasteWatcher

FDA Recognizes Value of Tobacco Harm Reduction

Regulators approve less-harmful alternative to tobacco.

Alec Mena February 6, 2025
State Action

CCAGW Urges Missouri Legislators to Oppose Senate Bills 45, 372, and 512

SB 45, SB 372, and SB 512 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmacy benefit managers in Missouri and increase prescription drug costs for patients.

Alec Mena February 6, 2025
State Action

CCAGW Urges Missouri Legislators to Oppose House Bills 474 and 840

HB 474 and HB 840 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmacy benefit managers in Missouri and increase prescription drug costs for patients.

Alec Mena February 6, 2025
State Action

CCAGW Urges North Dakota Legislators to Oppose House Bill 1473

HB 1473 would change how the federal 340B Drug Pricing Program operates in North Dakota. 

Alec Mena February 6, 2025

Pages